Public Release: 

SNM 'capitalizes' opportunity to meet with policymakers, regulators at annual meeting in D.C.

Issues of shared concern about molecular imaging and therapy and nuclear medicine to be discussed during many government relations sessions, activities at 54th annual meeting June 2-6

Society of Nuclear Medicine

RESTON, Va.--SNM, the world's largest society for molecular imaging and nuclear medicine professionals, will host a number of sessions and activities to educate policymakers and regulators about advances in this evolving field during its 54th Annual Meeting June 2-6 in Washington, D.C.

"Our location in the District of Columbia provides an excellent opportunity for the molecular imaging and therapy community to get together with policymakers and regulators to discuss issues of shared concern," said SNM President Martin P. Sandler. "This year we have increased the number of educational sessions presented by representatives from the Food and Drug Administration and the Centers for Medicare and Medicaid Services," he indicated. "Additionally, there will be a session on radiation safety regulation moderated by the Nuclear Regulatory Commission and specialty workshops provided by representatives from the National Institute of Biomedical Imaging and Bioengineering and the National Cancer Institute," said Sandler.

"We are certainly going to 'capitalize' on hosting our Annual Meeting in the Nation's Capital," said SNM Technologist Section President Scott Holbrook. "In addition to offering many diverse government agency programs, SNM and SNMTS members will travel to Capitol Hill on June 5 to visit their respective legislators and talk about public policy issues," he noted.

Here are some of the government relations-related sessions and activities that are planned.

  • National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering Workshop: "Molecular Biology for Imagers," 10 a.m.-5 p.m., June 2

  • NIH/National Cancer Institute: "NIH/NCI Workshop: Use of PET/CT in the Clinic and Clinical Trials: Quantitation for Change Analysis," 10 a.m.-5 p.m., June 2

  • Centers for Medicare and Medicaid Services: "Reimbursement and Coding: Approaches to Pay for Performance and CMS Quality Initiatives," 12:30-2 p.m., June 4
Thomas B. Valuck, medical officer and senior adviser to the director of Center for Medicare Management at CMS, who advises on clinical and policy issues related to Medicare's payment systems, will present "CMS Pay for Performance and Quality Initiatives" from 12:30-1:30 p.m.

  • Food and Drug Administration: "Research With Radiolabeled Drugs," 4:30-6 p.m., June 4

  • Nuclear Regulatory Commission: "NRC: Running an NRC-Compliant Radiation Safety Program," 9:45-11:15 a.m., June 5

  • Capitol Hill Day: Molecular Imaging and the Public Policy Agenda: 11 a.m.-3 p.m., June 5

  • Food and Drug Administration: "Final PET Drug Current Good Manufacturing Process (CGMP)" (tentative), 8-9:30 a.m., June 6

Researchers--covering the most recent advances in understanding, diagnosing and treating heart and brain diseases and cancer--release their findings in nearly 1,800 scientific abstracts during SNM's 54th Annual Meeting June 2-6 at the Washington Convention Center. More than 4,000 physicians, technologists, scientists and pharmacists will attend this meeting, the world's largest event for molecular imaging and nuclear medicine professionals. The educational and scientific program at the 54th Annual Meeting is tailored to provide attendees with the most current and important information available in the field. SNM and SNMTS present about 100 continuing education courses focusing on PET/CT, cardiovascular nuclear medicine, brain imaging, pediatrics, oncology and therapy, thyroid cancer and radiation safety.

To register for the meeting, visit the SNM Web site at http://www.snm.org/am. Press registration is complimentary to credentialed media. For press registration only, contact Maryann Verrillo, at (703) 652-6773 or mverrillo@snm.org. Press representatives may also register online at www.snm.org/am. SNM will hold a press conference from 11:30 a.m.-1 p.m. on Monday, June 4, featuring an overview of the latest research and discoveries in the world of molecular imaging/nuclear medicine. New applications in oncology, neurology and cardiology will be discussed. Also at this press conference, Henry N. Wagner Jr. will announce the 2007 Image of the Year.

###

About SNM--Advancing Molecular Imaging and Therapy

SNM is holding its 54th Annual Meeting June 2-6 at the Washington Convention Center in Washington, D.C. Session topics for the 2007 meeting include brain amyloid imaging, hybrid imaging, molecular imaging in clinical drug development and evaluation, functional brain imaging in epilepsy and dementia, imaging instrumentation, infection imaging, lymphoma and thyroid cancer, cardiac molecular imaging, general nuclear medicine, critical elements of care in radiopharmacy and more.

SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced--and continue to explore--biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.